Key result
Pulmonary thromboendarterectomy successfully restores perfusion in pediatric malignancy-associated septic chronic thromboembolic disease.
Why the study?
Chronic thromboembolic pulmonary hypertension is exceptionally rare in children and typically associated with major acquired prothrombotic conditions.
Case Report (n=1)
No
Pulmonary thromboendarterectomy is feasible and can achieve favorable outcomes in pediatric patients with chronic thromboembolic pulmonary hypertension, even in the setting of complex oncologic and infectious comorbidities.
Answers are grounded in this paper and cite their sources.
Supports feasibility of pulmonary thromboendarterectomy in pediatric malignancy-associated CTEPH; leaves open broader applicability pending prospective data.
BACKGROUND: Chronic thromboembolic pulmonary hypertension is exceptionally rare in children and is typically associated with major acquired prothrombotic conditions. CASE SUMMARY: We report a 14-year-old girl with acute lymphoblastic leukemia who developed chronic thromboembolic pulmonary artery obstruction following necrotizing pneumonia and septic thromboembolic disease. Computed tomography, ventilation-perfusion scintigraphy, and pulmonary angiography demonstrated complete right pulmonary arterial occlusion with absent perfusion to the right middle and lower lobe territories. Despite mildly elevated pulmonary artery pressures (mean pulmonary artery pressure 23 mm Hg), the patient presented with severe functional limitation, oxygen dependence, and surgically accessible disease. Bilateral pulmonary thromboendarterectomy was successfully performed, achieving restoration of pulmonary perfusion and favorable postoperative recovery. Molecular analysis of the resected thrombotic material identified Mycobacterium tuberculosis. DISCUSSION: This case highlights the feasibility of pulmonary thromboendarterectomy in pediatric chronic thromboembolic pulmonary hypertension and emphasizes that surgical candidacy should integrate symptom burden, anatomical operability, and multidisciplinary assessment beyond hemodynamic severity alone. TAKE-HOME MESSAGES: Pulmonary thromboendarterectomy is feasible and associated with favorable outcomes in pediatric patients and remains the only potentially curative treatment. Early multidisciplinary evaluation is essential to identify operable disease, integrating anatomical burden, clinical and hemodynamic status, and the risk of disease progression.
No takes yet. Share an insight, caveat, or question.
Duarte et al. (2026) conducted a case report in Chronic thromboembolic pulmonary hypertension (CTEPH) (n=1). Pulmonary thromboendarterectomy was evaluated on Restoration of pulmonary perfusion and postoperative recovery. Pulmonary thromboendarterectomy successfully restored pulmonary perfusion and resulted in a favorable postoperative recovery in a 14-year-old girl with malignancy-associated septic chronic thromboembolic disease.
Synapse has enriched 10 related papers. Consider them for comparative context: